A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
Clinical trial NCT05244551 · RECRUITING
Trial details
- NCT number
- NCT05244551
- Sponsor
- Abbisko Therapeutics Co, Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2025-04-30
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.